Federal Funding Opportunities

Browse federal grant and contract opportunities from Grants.gov and SAM.gov

Source:
Grants.gov SAM.gov All sources
Clear
Grants.gov HHS-FDA Forecasted
Critical Path Public Private Partnerships Clinical Trials Optional

Food and Drug Administration

The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD0…

Funding Range
$20,000,000.00 – $20,000,000.00
Total Funding
N/A
No close date
View Details
Grants.gov DOS-ITA Forecasted
U.S. Mission Italy PDS Annual Program Statement

U.S. Mission to Italy

U.S. DEPARTMENT OF STATE U.S. MISSION ITALY , PUBLIC DIPLOMACY SECTION (PDS) 2024 Annual Program Statement Funding Opportunity Title: U.S. Mission Italy PDS Annual Program Statement Funding Opportuni…

Funding Range
$20,000.00 – $75,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not …

Food and Drug Administration

The purpose of this FOA is to develop and maintain Rapid Response Teams (RRTs) to facilitate long-term improvements and innovation to the national integrated food safety system by unifying and coordi…

Funding Range
$360,000.00 – $1,440,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Collaborations to Enhance Drug Development and Regulatory Science

Food and Drug Administration

This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the Cr…

Funding Range
$5,000,000.00 – $5,000,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial …

Food and Drug Administration

FDA announces the availability of fiscal year (FY) 2024 funds to support one or more projects to 1) collect antimicrobial use data from diverse animal sectors, including domestic livestock, poultry, …

Funding Range
Up to $200,000.00
Total Funding
$600,000.00
No close date
View Details
Grants.gov HHS-NIH11 Posted
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)

National Institutes of Health

The National Institutes of Health (NIH) hereby notifies NIH award recipients that funds may be available for revision applications to support the expansion of existing projects and/or programs within…

Funding Range
Not specified
Total Funding
N/A
13 days left
View Details
Grants.gov HHS-FDA Forecasted
Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)

Food and Drug Administration

The purpose of this funding opportunity is to support the research and development necessary to advance non-invasive (e.g., quantitative tomography-based) technologies, including the development of a…

Funding Range
$250,000.00 – $250,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials …

Food and Drug Administration

The intended outcome of this Notice of Funding Opportunity (NOFO) is to advance efforts for a nationally Integrated Food Safety System (IFSS) by supporting Manufactured Food Regulatory Program Standa…

Funding Range
$340,000.00 – $1,285,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial …

Food and Drug Administration

The U.S. Food and Drug Administration (FDA) seeks applications to develop, implement, and evaluate a human abuse potential (HAP) study of botanical Kratom. FDA has previously warned consumers about t…

Funding Range
$2,000,000.00 – $2,000,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution …

Food and Drug Administration

The purpose of this funding opportunity is to examine the utility of an in vitro simulated gastrointestinal (GI) dissolution model for the assessment of in vitro performance of amorphous solid disper…

Funding Range
$250,000.00 – $500,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical …

Food and Drug Administration

The purpose of this research is to systematically evaluate the diastereomeric composition of LEQVIO (Inclisiran), an FDA-approved, N-acetyl galactosamine (GalNAc)-conjugated siRNA drug, and to unders…

Funding Range
$300,000.00 – $300,000.00
Total Funding
N/A
No close date
View Details
Grants.gov HHS-FDA Forecasted
Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release …

Food and Drug Administration

Modified release (MR) oral drug products are considered to have a high risk for alcohol dose dumping (ADD) because they contain large quantities of drug(s), designed to release over a prolonged perio…

Funding Range
$250,000.00 – $250,000.00
Total Funding
N/A
No close date
View Details